Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Enveric Biosciences Inc (ENVB)
Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enveric Biosciences Inc 4851 TAMIAMI TRAIL N SUITE 200 NAPLES FL 34103 USA

P: 239-302-1707

Description:

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

Key Statistics

Overview:

Market Capitalization, $K 5,040
Enterprise Value, $K -11,790
Shares Outstanding, K 2,182
Annual Sales, $ 0 K
Annual Net Income, $ -18,470 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,360 K
EBIT, $ -20,730 K
EBITDA, $ -12,840 K
60-Month Beta 1.30
% of Insider Shareholders 3.00%
% of Institutional Shareholders 8.75%
Float, K 2,116
% Float 97.00%
Short Volume Ratio 0.74

Growth:

1-Year Return -48.15%
3-Year Return -99.12%
5-Year Return -99.96%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.76%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.04 on 08/14/23
Next Earnings Date 11/13/23
Earnings Per Share ttm -7.47
EPS Growth vs. Prev Qtr -36.94%
EPS Growth vs. Prev Year -11.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 07/15/22

ENVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -111.64%
Return-on-Assets % -77.49%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.92
Book Value/Share 2.34
Interest Coverage -1,995.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar